ScholarIQanswers from OpenAlex & ORCID
Jens Ricke
ResearcherPublications, citations & collaboration network
Jens Ricke is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Jens Ricke have?
ScholarIQindexed works
Jens Ricke has 972 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Jens Ricke have?
ScholarIQcitation count
Jens Ricke has 23,305 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Jens Ricke?
ScholarIQh-index
Jens Ricke has an h-index of 62 in OpenAlex.
What is the i10-index of Jens Ricke?
ScholarIQi10-index
Jens Ricke has an i10-index of 327 in OpenAlex.
What is the ORCID of Jens Ricke?
ScholarIQorcid
The ORCID for Jens Ricke is on the source record.
What is the OpenAlex record for Jens Ricke?
ScholarIQopenalex
The OpenAlex for Jens Ricke is on the source record.
What are the most-cited papers on Jens Ricke?
ScholarIQmost cited works
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer
Alessandra Gennari, Fabrice André, Carlos H. Barrios, Javier Cortés, Evandro de Azambuja, A. DeMichele, Rebecca Dent, Deborah Fenlon, Joseph Gligorov, Sara A. Hurvitz, Seock‐Ah Im, David Krug, Wolfgang G. Kunz, Sherene Loi, Frédérique Penault‐Llorca, Jens Ricke, Mark E. Robson, Hope S. Rugo, Cristina Saura, Peter Schmid, Christian F. Singer, Tanja Španić, Sara M. Tolaney, Nicholas C. Turner, Giuseppe Curigliano, Sibylle Loibl, Shani Paluch–Shimon, Nadia Harbeck
Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma
Jens Ricke, Heinz‐Josef Klümpen, Holger Amthauer, Irene Bargellini, Peter Bartenstein, Enrico N. De Toni, Antonio Gasbarrini, Maciej Pech, Markus Peck‐Radosavljevic, Peter Popovič, Olivier Rosmorduc, Eckart Schott, Max Seidensticker, Chris Verslype, Bruno Sangro, Peter Malfertheiner
First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials
Harpreet Wasan, Peter Gibbs, Navesh Sharma, Julien Taı̈eb, Volker Heinemann, Jens Ricke, Marc Peeters, Michael Findlay, Andrew Weaver, Jamie Mills, Charles Wilson, Richard Adams, Anne Francis, Joanna Moschandreas, Pradeep S. Virdee, Peter Dutton, Sharon Love, Val Gebski, Alastair Gray, Richard Adams, Andrew Bateman, Claire Blesing, Ewan Brown, Ian Chau, Sebastian Cummins, David Cunningham, Stephen Falk, Maher Hadaki, Marcia Hall, Tamas Hickish, Joanne Hornbuckle, F. Lofts, Sarah Lowndes, Astrid Mayer, Matthew S. Metcalfe, Gary Middleton, Jamie Mills, Amir Montazeri, R. Muirhead, Andreas Polychronis, Colin Purcell, Paul J. Ross, Ricky A. Sharma, Liz Sherwin, David Smith, Rubin Soomal, Daniel Swinson, Axel Walther, Harpreet Wasan, Andrew Weaver, Charles Wilson, Greg Wilson, Pradip Amin, Bruna Angelelli, Jacques Balosso, Alex Beny, Daniel Bloomgarden, Evelyn Boucher, Michael D. Brown, Harald-Robert Bruch, James Bui, Matthew Burge, Giuseppe Cardaci, James Carlisle, Seungjean Chai, Yi‐Jen Chen, P. Chevallier, Michael Chuong, Stephen Clarke, Andrew L. Coveler, M Craninx, Thierry Delanoit, Amélie Deleporte, Paul Eliadis, Francis Facchini, Thomas W. Ferguson, Michel Ferrante, Michael Findlay, Gary Frenette, Jacob Frick, Vinod Ganju, Michael Garofalo, Karen Geboes, Gerald Gehbauer, Benjamin George, Ravit Geva, Peter Gibbs, Melita A. Gordon, Kate Gregory, Seza A. Güleç, James Hannigan, Guy van Hazel, Norman Heching, Volker Heinemann, Thomas Helmberger, Alain Hendlisz, Koen Hendrickx, Matthew P. Holtzman, Richard Isaacs, Christopher Jackson
Well-Differentiated Pancreatic Nonfunctioning Tumors/Carcinoma
Massimo Falconi, Ursula Plöckinger, Dik J. Kwekkeboom, Riccardo Manfredi, Meike Körner, Larry K. Kvols, Ulrich F. Pape, Jens Ricke, Peter E. Goretzki, Stefan Wildi, Thomas Steinmüller, Kjell Öberg, Jean‐Yves Scoazec